Mabion-AI2

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMabion-AI2
Drug Alias Nameautoimmune disease mAb biosimilar-1 (Mabion)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMabion Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMabion Sa
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A